Drugs / SL4903
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07234721 | Feb 2026 → Mar 2028 expected | refractory plasma cell neoplasm | Institute of Hematology & Blood Diseases Hospital, China | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SL4903 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07234721 ↗ |
| Modality | Cell therapy | “SL4903 autologous T-cell injection (CAR-T cell therapy)” NCT07234721 ↗ |